Assobiotec - English version

13 September 2023

HealthTech Innovation Days 2023 Program announced

Flagship event in the European health innovation ecosystem, organized in Paris with the support of Life Sciences Leaders

19 July 2023

HealthTech For Care, its sponsors, and supporters adapt the 5th edition of HealthTech Innovation Days to the uncertain economic and financial context in Europe

The development of medical innovation for the benefit of European patients is going through uncertain financial times. The economic impact on the development of European HealthTech companies is a real challenge. In order to support medical innovation for the benefit of patients, HealthTech For Care, its sponsors and supporters are providing a concrete solution for these companies through HealthTech Innovation Days (HTID), by modifying the participation criteria for companies, in order to welcome early-stage companies.

18 July 2023

Biotechnology: a strategic and growing sector with over 13 billion in turnover

More than 800 companies, 13,700 employees, over 13 billion in turnover estimated in 2022 and a market that is recording growth on various variables testifying to a resilient, dynamic and strategic sector for the development of the country. This is what emerges from the economic update of the ENEA-Assobiotec report "Biotechnology companies in Italy", now in its 8th edition, presented today in an online event.

27 June 2023

“Innovit for Life Sciences > Road to #JPM24” is ready to go

A series of appointments to bring the American investors’ attention on the excellences of the Life Science Industry in Italy

01 June 2023

Axxam and Promega announce agreement to develop smart assays for drug discovery services

Axxam and Promega announced formalization of an agreement that will offer world-class early-stage drug discovery services for different classes of targets and cellular pathways. Global clients will have facilitated access to innovative customized luminescence-based, cell-free and cell-based assays suitable to run in miniaturized and fully automated High-Throughput Screening (HTS) format, in search of novel drug candidates.

18 May 2023

First results of the collaboration between Olon Group, Biosphere and the University of Amsterdam on biocatalysis project

The partnership, which will be continued in the future with other research projects, brings together some of the most advanced expertise in the field of biocatalysis from both academic and industrial spheres, to implement large-scale biocatalysis as an industrial technology used within its production facilities in Italy and around the world.

Go to the

Events

News

HealthTech Innovation Days 2023 Program announced

HealthTech For Care, its sponsors, and supporters adapt the 5th edition of HealthTech Innovation Days to the uncertain economic and financial context in Europe

Biotechnology: a strategic and growing sector with over 13 billion in turnover

“Innovit for Life Sciences > Road to #JPM24” is ready to go

Axxam and Promega announce agreement to develop smart assays for drug discovery services

First results of the collaboration between Olon Group, Biosphere and the University of Amsterdam on biocatalysis project

Partner

Where to find us